RobotEra Raises $423M Across Two Strategic Rounds in 30 Days
RobotEra closed two strategic financing rounds in less than five weeks — a $143 million round on March 24 led by Gaocheng Capital, Singtel Innov8, and Woori Venture Partners, followed by a RMB 2B+ (~$280 million) follow-on on April 8. Combined with prior funding, the Beijing-based humanoid maker has now raised $674 million total, joining the small group of Chinese humanoid startups with cumulative funding above the half-billion mark.
The back-to-back rounds reflect a pattern emerging across Chinese humanoid manufacturers in 2026: privately-disclosed order backlog driving rapid follow-on capital. RobotEra disclosed more than $72.7 million in cumulative orders as of March, anchoring the valuation step from ~$1.5B in March to an estimated ~$1.8B in April.
Where RobotEra fits in the Chinese humanoid stack
RobotEra was spun out of Tsinghua University and has positioned itself in the logistics and light-industrial deployment segment — different from the consumer focus of 1X or the heavy-industrial focus of Apptronik. Its L7 humanoid platform is being deployed in warehouse and last-mile logistics applications across Chinese e-commerce providers and 3PL operators, where the customer ROI calculation depends on labor cost replacement at lower per-unit pricing than Western competitors charge.
The company's strategy of revenue-then-capital — securing orders before raising larger rounds — contrasts with the Western model of speculative platform funding. It also explains why two strategic rounds were possible in such close succession: each one was justified by demonstrable commercial traction rather than narrative alone.
The Chinese humanoid capital flywheel intensifies
RobotEra's $674M total now puts it ahead of Astribot ($100M+), behind AGIBot ($284M+), and roughly comparable to UBTECH ($940M+) by published total. The expanding cohort of $500M+ Chinese humanoid manufacturers — RobotEra, Galbot ($345M+), NEURA Robotics ($2.1B+ at €4B Series D in March), AGIBot, UBTECH, Unitree — now collectively exceeds the total disclosed funding of all Western humanoid manufacturers outside Figure AI and Apptronik.
The geography of capital is shifting. Where 2023-2024 humanoid funding was dominated by US Series rounds led by SoftBank, Microsoft, and Bezos Expeditions, 2026 has tilted toward Chinese strategic and state-linked capital. The pattern points to a bifurcating global humanoid market — Western premium platforms targeting enterprise contracts at $50-100K per unit, Chinese commodity platforms targeting volume at $10-30K per unit.
What to watch
RobotEra's April round explicitly named "logistics deployment scaling" as the use of proceeds. With $280M of fresh capital and an order book that already disclosed at $72M+, the company is in position to be one of the first Chinese humanoid manufacturers to publicly disclose annualized revenue. If RobotEra discloses revenue figures comparable to Unitree's ¥1.7B in 2025, it would mark a structural shift in how humanoid manufacturers are valued — from speculative platform multiples to revenue multiples.